Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India

Background: To investigate the factors affecting treatment outcome of extensively drug resistant tuberculosis (XDR-TB) in Gujarat, India. Methods: A prospective, observational study was conducted on patients with XDR TB from January 2012 to October 2016. Details of demography, clinical symptoms, spu...

Full description

Bibliographic Details
Main Authors: Krunal Prajapati, Vishal Mishra, Mira Desai, Rajesh Solanki, Purvi Naik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=3;spage=289;epage=295;aulast=Prajapati
_version_ 1819153305697255424
author Krunal Prajapati
Vishal Mishra
Mira Desai
Rajesh Solanki
Purvi Naik
author_facet Krunal Prajapati
Vishal Mishra
Mira Desai
Rajesh Solanki
Purvi Naik
author_sort Krunal Prajapati
collection DOAJ
description Background: To investigate the factors affecting treatment outcome of extensively drug resistant tuberculosis (XDR-TB) in Gujarat, India. Methods: A prospective, observational study was conducted on patients with XDR TB from January 2012 to October 2016. Details of demography, clinical symptoms, sputum/culture and radiological examination, drug treatment, adverse drug reactions (ADRs) and treatment outcome were recorded in pretested case record form (CRF). Data was analyzed using Fisher's exact test and paired student's t test. Results: Out of 112 patients, 83 (74%) were men and 29 (26%) were women and majority of belonged to age group of 16 – 45 years. Majority of patients (79%) received standardized treatment. A total of 61 (54%) patients converted to sputum culture negative by 12 months and out of these, 49 turned sputum culture negative within initial 6 months of treatment. Successful treatment outcome was seen in 29 (25.89 %). Age ≤40 years (P<0.05), body mass index > 18.5 (P<0.05) and sputum/culture conversion at three month (P<0.001) were positive predictors for successful treatment outcome, while tobacco chewing habit (P<0.05) and alcohol consumption (P<0.05) were negative predictors for the successful treatment outcome. Out of 83 (74.1 %) patients with unsuccessful treatment outcome, 58 (51.78 %) died, 11 (9.82 %) were defaulter and 10 (8.92 %) were treatment failure. Factors positively associated with death were very low BMI (< 18.5), concomitant diseases and harmful personal habits. Conclusions: Treatment outcome of XDR TB patients is extremely poor with high mortality rate.
first_indexed 2024-12-22T15:03:05Z
format Article
id doaj.art-af49eee9647248f9829748afa68beead
institution Directory Open Access Journal
issn 2212-5531
2212-554X
language English
last_indexed 2024-12-22T15:03:05Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Mycobacteriology
spelling doaj.art-af49eee9647248f9829748afa68beead2022-12-21T18:22:04ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2017-01-016328929510.4103/ijmy.ijmy_59_17Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, IndiaKrunal PrajapatiVishal MishraMira DesaiRajesh SolankiPurvi NaikBackground: To investigate the factors affecting treatment outcome of extensively drug resistant tuberculosis (XDR-TB) in Gujarat, India. Methods: A prospective, observational study was conducted on patients with XDR TB from January 2012 to October 2016. Details of demography, clinical symptoms, sputum/culture and radiological examination, drug treatment, adverse drug reactions (ADRs) and treatment outcome were recorded in pretested case record form (CRF). Data was analyzed using Fisher's exact test and paired student's t test. Results: Out of 112 patients, 83 (74%) were men and 29 (26%) were women and majority of belonged to age group of 16 – 45 years. Majority of patients (79%) received standardized treatment. A total of 61 (54%) patients converted to sputum culture negative by 12 months and out of these, 49 turned sputum culture negative within initial 6 months of treatment. Successful treatment outcome was seen in 29 (25.89 %). Age ≤40 years (P<0.05), body mass index > 18.5 (P<0.05) and sputum/culture conversion at three month (P<0.001) were positive predictors for successful treatment outcome, while tobacco chewing habit (P<0.05) and alcohol consumption (P<0.05) were negative predictors for the successful treatment outcome. Out of 83 (74.1 %) patients with unsuccessful treatment outcome, 58 (51.78 %) died, 11 (9.82 %) were defaulter and 10 (8.92 %) were treatment failure. Factors positively associated with death were very low BMI (< 18.5), concomitant diseases and harmful personal habits. Conclusions: Treatment outcome of XDR TB patients is extremely poor with high mortality rate.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=3;spage=289;epage=295;aulast=PrajapatiCorrelationextensively drug resistant tuberculosistreatment outcome
spellingShingle Krunal Prajapati
Vishal Mishra
Mira Desai
Rajesh Solanki
Purvi Naik
Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
International Journal of Mycobacteriology
Correlation
extensively drug resistant tuberculosis
treatment outcome
title Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
title_full Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
title_fullStr Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
title_full_unstemmed Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
title_short Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India
title_sort treatment outcome of patients having extensively drug resistant tuberculosis in gujarat india
topic Correlation
extensively drug resistant tuberculosis
treatment outcome
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=3;spage=289;epage=295;aulast=Prajapati
work_keys_str_mv AT krunalprajapati treatmentoutcomeofpatientshavingextensivelydrugresistanttuberculosisingujaratindia
AT vishalmishra treatmentoutcomeofpatientshavingextensivelydrugresistanttuberculosisingujaratindia
AT miradesai treatmentoutcomeofpatientshavingextensivelydrugresistanttuberculosisingujaratindia
AT rajeshsolanki treatmentoutcomeofpatientshavingextensivelydrugresistanttuberculosisingujaratindia
AT purvinaik treatmentoutcomeofpatientshavingextensivelydrugresistanttuberculosisingujaratindia